Verrica Pharmaceuticals buy Royal Bank of Canada
Start price
04.10.24
/
50%
€1.27
Target price
04.10.25
€10.03
Performance (%)
-53.06%
End price
05.10.25
-
Summary
This prediction is currently being closed. Massive losses of -53.06% have been the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Royal_Bank_of_Canada for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.60
15.08.24
15.08.24
€11.83
15.08.25
15.08.25
-77.02%
16.08.25
16.08.25
